- Clinical Trials
- February 2020
- 106 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Drug Pipelines
- August 2018
- 113 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- February 2022
- 124 Pages
Global
From €4324EUR$4,500USD£3,697GBP
Chronic Pancreatitis Pain Drugs are a subset of Immune Disorders Drugs, used to treat the chronic pain associated with pancreatitis. These drugs are typically used to reduce inflammation and pain, and to improve the quality of life for those suffering from the condition. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, antispasmodics, and anticonvulsants. In some cases, surgery may be recommended to reduce the severity of the condition.
The Chronic Pancreatitis Pain Drug market is highly competitive, with a range of companies offering products to treat the condition. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more